20171016-三星证券-Samsung_Healthcare_Weekly_17页_1mb

Sector Update Summary

Core Content

This document provides an overview of the performance and valuation metrics for the Korean healthcare sector and global biotechnology, life sciences tools, and services firms. It includes rankings, market capitalization, forward P/E and P/B ratios, and year-to-date (YTD) returns for the top 20 companies in the Korean market and the global healthcare sector. The report also features charts and tables detailing the performance of various indices and specific companies within the healthcare and biotechnology sectors.

Main Points

Korean Stock Market: Top 20

• Samsung Electronics leads with the highest market cap at 350.4 KRWt and a YTD return of 49.8%.
• SK Hynix is the second with a market cap of 62.7 KRWt and a significant YTD return of 92.6%.
• Celltrion + Celltrion Healthcare ranks fourth with a market cap of 29.3 KRWt and a YTD return of 51.1%.
• Samsung Biologics is ranked 8th with a market cap of 25.7 KRWt and a high YTD return of 157.3%, indicating strong performance.
• AmorePacific ranks 20th with a market cap of 15.8 KRWt and a negative YTD return of -15.7%.

Global Biotechnology, Life Sciences Tools and Services Firms: Top 20

• AbbVie is the leader with a market cap of 144.5 USD and a YTD return of 44.8%.
• Amgen ranks second with a market cap of 133.5 USD and a YTD return of 25.2%.
• Celltrion + Celltrion Healthcare is 14th with a market cap of 26.0 USD and a YTD return of 51.1%.
• Samsung Biologics ranks 16th with a market cap of 22.8 USD and a YTD return of 157.3%, showing exceptional growth.
• Vertex Pharmaceuticals is 10th with a market cap of 38.6 USD and a YTD return of 107.6%, indicating high volatility.

Global Healthcare Indices

• Korea: KRX Health Care and Kospi Medical Supplies indices show strong YTD returns, while Kosdaq Medical and Precision Machines has a negative return.
• US: S&P 500 Healthcare and Nasdaq Biotechnology indices have positive YTD returns, but S&P 500 Healthcare equipment and services has a slight negative return.
• Europe: MSCI Europe Healthcare and Pharm/Bio indices have mixed performances, with some showing positive and others negative returns.
• Japan: MSCI Japan Healthcare and related indices have moderate YTD returns.
• China: MSCI China Healthcare has a significant YTD return of 32.2%.
• India: MSCI India Healthcare has a negative YTD return of -8.7%.

Key Information

Performance Highlights

• Samsung Biologics and Celltrion + Celltrion Healthcare are among the top performers in both the Korean and global rankings.
• Amgen and AbbVie are top global performers in the biotechnology sector.
• Korea's healthcare sector is dominated by large companies like Samsung Electronics, SK Hynix, and Hyundai Motor.

Valuation Metrics

• Forward P/E and Forward P/B ratios vary widely, reflecting different growth potentials and valuations.
• Samsung Biologics has a very high forward P/E ratio of 413.8, suggesting high expectations for future earnings.
• AmorePacific has a high forward P/E ratio of 31.4 but a negative YTD return, indicating potential overvaluation.

Market Share

• KRX Health Care accounts for 6.2% of the total market.
• Kospi Medical Supplies and Kosdaq Pharmaceuticals show a significant portion of the market, with Kosdaq Pharmaceuticals at 2.5%.
• Kosdaq Medical and Precision Machines has a smaller market share, at 0.4%.

Summary of Major Korean Healthcare Firms

Pharmaceuticals

• Hanmi Science and Green Cross Holdings are among the top pharmaceutical companies in Korea.
• Daewoong and Donga Socio Holdings show mixed performance with varying YTD returns.
• Samsung Biologics and Celltrion are notable for their high market caps and strong YTD returns.

Medical Devices

• Osstem Implant and Dentium are leading companies in the medical devices sector.
• Dio and Interojo show positive performance with varying YTD returns.

Diagnostics

• Boditech Med and i-Sens are top performers in the diagnostics category.
• Access Bio and Green Cross Medical Science show high P/E ratios and mixed performance.

New Drug Development

• Sillajen and ViroMed are notable for their high P/E ratios and performance in the new drug development sector.

Functional Foods

• Naturalendo Tech and Su-Heung are key players in the functional foods sector with varying returns.

Beauty Care

• Medytox and Hugel are leading in the beauty care sector, with Medytox showing a strong market cap.

Stem Cell Therapy

• Medipost and Chabiotech are leading companies in the stem cell therapy segment, with varying performance metrics.

Immune Cell Therapy

• Green Cross Cell and JW Shinyak are significant players with positive returns.

Molecular Diagnostics

• Seegene and Panagene are key companies in molecular diagnostics, with varying performance and valuations.

Genome Analysis

• Macrogen and Theragen Etex are leading in genome analysis, showing mixed results.

This summary highlights the performance and valuation dynamics of key companies and indices in the healthcare and biotechnology sectors, providing insights into market trends and investment opportunities.